After six months, surgical patients experienced a 60% drop in nighttime throat obstructions compared to 20% for those on medical treatment, and the results remained stable at follow-up two to three years later.
Following a single treatment with RhinAer, symptom severity significantly decreased in the first two weeks and remained low through the one-year follow-up.
BoxBar Vascular, under the leadership of board certified surgeon Ellen Derrick, MD MPH FACS, opened its doors in Seattle this month with a mission to improve not only the vascular health and well-being of patients but their...
Read More
CPAP is the gold standard for obstructive sleep apnea, but what about patients who can’t—or won’t—tolerate it or who need an additional therapy? We profile the spectrum of FDA-approved therapies, including when to try them, considerations for each, and new developments.
Read MoreCraig Schwimmer, MD, MPH, FACS, founder and CEO of Snoring Center USA LLC, announced the formation of Pillar Palatal LLC, and its acquisition of the Pillar Procedure business from Medtronic Inc, effective January 17, 2014. The...
Read MoreHealth Canada has approved sale of St Paul, Minn-based, Restore Medical’s Pillar® Palatal Implant System, providing Canadians access to the FDA-cleared palatal implant to treat snoring and mild-to-moderate obstructive sleep apnea (OSA).
Read More